| Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide's anti-leukemic activity. | |
| | |
MedLine Citation:
|
PMID: 23318959 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Parthenolide is selectively toxic to leukemia cells; however, it also activates cell protective responses which may limit its clinical application. Therefore, we sought to identify agents that synergistically enhance parthenolide's cytotoxicity. Using a high-throughput combination drug screen, we identified the hypoglycemic, vildagliptin, which synergized with parthenolide to induce death of the leukemia stem cell line, TEX (combination index (CI) = 0.36 and 0.16, at EC 50 and 80, respectively; where CI < 1 denotes statistical synergy). The combination of parthenolide and vildagliptin reduced the viability and clonogenic growth of cells from acute myeloid leukemia patients and had limited effects on the viability of normal human peripheral blood stem cells. The basis for synergy was independent of vildagliptin's primary action as an inhibitor of dipeptidyl peptidase (DPP) IV. Rather, using chemical and genetic approaches we demonstrated that the synergy was due to inhibition of the related enzymes DPP8 and 9. In summary, these results highlight DPP8 and 9 inhibition as a novel chemosensitizing strategy in leukemia cells. Moreover, these results suggest that the combination of vildagliptin and parthenolide could be useful for the treatment of leukemia.Leukemia accepted article preview online, 15 January 2013; doi:10.1038/leu.2013.9. |
| | |
Authors:
|
P A Spagnuolo; R Hurren; M Gronda; N Maclean; A Datti; A Basheer; F-H Lin; X Wang; J Wrana; A D Schimmer |
Related Documents
:
|
20117099 - Progenitor cell-derived smooth muscle cells in vascular disease. 23600999 - Atopic dermatitis complicated by eczema herpeticum is associated with hla b7 and reduce... 23225889 - Isolation of human cd4/cd8 double-positive, graft-versus-host disease-protective, minor... 23093039 - Examination of thymic positive and negative selection by flow cytometry. 15875519 - Stem cell therapy for cardiac arrhythmias. 23143309 - Herv-k-specific t cells eliminate diverse hiv-1/2 and siv primary isolates. 16783719 - Cutaneous t-cell lymphoma in a heifer with increased serum lactate dehydrogenase activity. 9252129 - Different functions of the gtpase rho in prothymocytes and late pre-t cells. 17224009 - Effect of a bone marrow microenvironment on the ex-vivo expansion of umbilical cord blo... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-1-15 |
Journal Detail:
|
Title: Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K Volume: - ISSN: 1476-5551 ISO Abbreviation: Leukemia Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-1-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8704895 Medline TA: Leukemia Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
School of Pharmacy, University of Waterloo, Kitchener Ontario, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.
Next Document: Impairing MLL-fusion gene mediated transformation by dissecting critical interactions with the lens ...